Study Information

Title: A Phase 2 of Entospletinib in Subjects With Relapsed or Refractory Hematologic Malignancies External
Status: Recruiting participants
Conditions: Chronic Lymphocytic Leukemia; Mantle Cell Lymphoma; Diffuse Large B-cell Lymphoma; Non-FL Indolent Non-Hodgkin's Lymphoma; Follicular Lymphoma
Interventions: Drug: Entospletinib; Drug: Entospletinib SDD
Institutions: Tufts Medical Center
Health Topics: Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma

Contact Information


Tufts Medical Center
Boston, MA 02111
Colleen Loiselle
617-636-2683
cloiselle@tuftsmedicalcenter.org